PHASE 3 COMPARISON OF HIGHER-DOSE LIPROTAMASE, A NONPORCINE PANCREATIC ENZYME REPLACEMENT THERAPY, TO PANCRELIPASE ON FAT AND PROTEIN ABSORPTION IN SUBJECTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS

Konstan M.; Wagener J.; Wilschanski M.; Gangal M.; Martin R. S.; Pennington J.

首页> 外文期刊>Pediatric Pulmonology >PHASE 3 COMPARISON OF HIGHER-DOSE LIPROTAMASE, A NONPORCINE PANCREATIC ENZYME REPLACEMENT THERAPY, TO PANCRELIPASE ON FAT AND PROTEIN ABSORPTION IN SUBJECTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS

【24h】

PHASE 3 COMPARISON OF HIGHER-DOSE LIPROTAMASE, A NONPORCINE PANCREATIC ENZYME REPLACEMENT THERAPY, TO PANCRELIPASE ON FAT AND PROTEIN ABSORPTION IN SUBJECTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS

机译：较高剂量脂溶酶，一种非孢碱胰酶替代疗法的相3比较，对囊性纤维化引起的受试者脂肪和蛋白质吸收的胰腺和蛋白质吸收

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric Pulmonology》 |2018年第2期|共1页
作者
Konstan M.; Wagener J.; Wilschanski M.; Gangal M.; Martin R. S.; Pennington J.;
展开▼
作者单位

Case Western Reserve Univ Sch Med Cleveland OH USA;

Univ Colorado Aurora CO USA;

Hadassah Med Ctr Jerusalem Israel;

Anthera Pharmaceut Hayward CA USA;

Anthera Pharmaceut Hayward CA USA;

Anthera Pharmaceut Hayward CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
专利

1. PHASE 3 COMPARISON OF HIGHER-DOSE LIPROTAMASE, A NONPORCINE PANCREATIC ENZYME REPLACEMENT THERAPY, TO PANCRELIPASE ON FAT AND PROTEIN ABSORPTION IN SUBJECTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS [J] . Konstan M., Wagener J., Wilschanski M., Pediatric Pulmonology . 2018,第Suppla2期

机译：较高剂量脂溶酶，一种非孢碱胰酶替代疗法的相3比较，对囊性纤维化引起的受试者脂肪和蛋白质吸收的胰腺和蛋白质吸收
2. Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption [J] . Calvo-Lerma Joaquim, Martínez-Barona Sandra, Masip Etna, Revista Espaola de Enfermedades Digestivas . 2017,第10期

机译：囊性纤维化的胰酶替代治疗：剂量，变异性和脂肪吸收系数
3. Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption [J] . Calvo-Lerma Joaquim, Martínez-Barona Sandra, Masip Etna, Revista Espaola de Enfermedades Digestivas . 2017,第10期

机译：囊性纤维化的胰酶替代治疗：剂量，变异性和脂肪吸收系数
4. The Proteomic Analysis of Pancreatic Exocrine Insufficiency Protein Marker in Type 2 Diabetes Mellitus Patients [C] . Arie Srihardyastutie, D W Soeatmadji, Fatchiyah International Conference on Chemistry and Material Science . 2018

机译：2型糖尿病患者胰腺外蛋白蛋白标志物的蛋白质组学分析
5. Assessing pancreatic enzyme efficacy in patients with cystic fibrosis: Evaluation of a combination approach using unprotected pancreatic enzymes and pH-sensitive enteric-coated microspheres. [D] . Kalnins, Daina Brigita. 2003

机译：评估囊性纤维化患者的胰酶功效：使用未保护的胰酶和pH敏感的肠溶微球的组合方法评估。
6. Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis [O] . Michael W. Konstan, Theodore G. Liou, Steven D. Strausbaugh, 2010

机译：新型胰酶（Ultrase MT20）治疗囊性纤维化外分泌性胰腺功能不全的吸收不良的疗效和安全性
7. Evaluation of growth in peri-pubertal cystic fibrosis (CF) subjects with exocrine pancreatic insufficiency (EPI) treated with the novel non-porcine pancreatic enzyme replacement therapy liprotamase [O] . Stevens C., Breetman L., Campion M., 2010

机译：新型非猪胰酶替代疗法脂蛋白酶治疗的外分泌性胰腺功能不全（EPI）的青春期周围囊性纤维化（CF）受试者的生长评估

PHASE 3 COMPARISON OF HIGHER-DOSE LIPROTAMASE, A NONPORCINE PANCREATIC ENZYME REPLACEMENT THERAPY, TO PANCRELIPASE ON FAT AND PROTEIN ABSORPTION IN SUBJECTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS

著录项

相似文献

相关主题

期刊订阅